Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1-Dependent IRE1α-XBP1 Pathway
{{output}}
Atractylenolide I (AO-I), a major pharmacological ingredient derived from Atractylodes macrocephala, has been reported to possess multiple bioactivities. This study aimed to investigate the potential protective effects of AO-I against lipotoxicity in both cult... ...